The Mass Spectrometry Center empowers clients from drug discovery to product release by providing comprehensive mass spectrometry analysis in the whole lifecycle of product development. This support includes but is not limited to, molecular weight analysis, sequence confirmation, post-translational modifications, sequence variants analysis, unknown component analysis, advanced protein characterization, NDC drug distribution, DAR, residual host cell protein characterization, nucleic acid molecular weight analysis, mRNA capping, Poly A distribution, etc.